nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Hypokinesia—Irinotecan—colon cancer	0.0328	0.0333	CcSEcCtD
Levorphanol—Respiratory failure—Vincristine—colon cancer	0.0231	0.0235	CcSEcCtD
Levorphanol—Coma—Vincristine—colon cancer	0.0208	0.0211	CcSEcCtD
Levorphanol—Coma—Fluorouracil—colon cancer	0.0194	0.0197	CcSEcCtD
Levorphanol—Extrasystoles—Capecitabine—colon cancer	0.0176	0.0179	CcSEcCtD
Levorphanol—Hypoxia—Methotrexate—colon cancer	0.0174	0.0176	CcSEcCtD
Levorphanol—Amnesia—Fluorouracil—colon cancer	0.0164	0.0166	CcSEcCtD
Levorphanol—Lethargy—Fluorouracil—colon cancer	0.0157	0.0159	CcSEcCtD
Levorphanol—Cardiac arrest—Vincristine—colon cancer	0.0157	0.0159	CcSEcCtD
Levorphanol—Urinary retention—Vincristine—colon cancer	0.0157	0.0159	CcSEcCtD
Levorphanol—Cyanosis—Methotrexate—colon cancer	0.0156	0.0158	CcSEcCtD
Levorphanol—Cardiac arrest—Irinotecan—colon cancer	0.0153	0.0155	CcSEcCtD
Levorphanol—Injection site reaction—Capecitabine—colon cancer	0.0147	0.0149	CcSEcCtD
Levorphanol—Cardiac arrest—Fluorouracil—colon cancer	0.0146	0.0148	CcSEcCtD
Levorphanol—Dysuria—Vincristine—colon cancer	0.0133	0.0135	CcSEcCtD
Levorphanol—Apnoea—Methotrexate—colon cancer	0.013	0.0132	CcSEcCtD
Levorphanol—Abnormal vision—Capecitabine—colon cancer	0.0129	0.0131	CcSEcCtD
Levorphanol—Mental disability—Capecitabine—colon cancer	0.0129	0.013	CcSEcCtD
Levorphanol—Sweating—Vincristine—colon cancer	0.0122	0.0124	CcSEcCtD
Levorphanol—Renal failure—Irinotecan—colon cancer	0.0122	0.0123	CcSEcCtD
Levorphanol—Sweating—Irinotecan—colon cancer	0.0119	0.012	CcSEcCtD
Levorphanol—Amnesia—Capecitabine—colon cancer	0.0114	0.0116	CcSEcCtD
Levorphanol—Bradycardia—Irinotecan—colon cancer	0.0113	0.0115	CcSEcCtD
Levorphanol—Respiratory failure—Methotrexate—colon cancer	0.0112	0.0114	CcSEcCtD
Levorphanol—Lethargy—Capecitabine—colon cancer	0.011	0.0111	CcSEcCtD
Levorphanol—Diplopia—Capecitabine—colon cancer	0.0107	0.0109	CcSEcCtD
Levorphanol—Visual impairment—Irinotecan—colon cancer	0.0107	0.0109	CcSEcCtD
Levorphanol—Flushing—Irinotecan—colon cancer	0.0103	0.0105	CcSEcCtD
Levorphanol—Cardiac arrest—Capecitabine—colon cancer	0.0102	0.0104	CcSEcCtD
Levorphanol—Urinary retention—Capecitabine—colon cancer	0.0102	0.0104	CcSEcCtD
Levorphanol—Mood swings—Capecitabine—colon cancer	0.0102	0.0103	CcSEcCtD
Levorphanol—Coma—Methotrexate—colon cancer	0.0101	0.0102	CcSEcCtD
Levorphanol—Arrhythmia—Irinotecan—colon cancer	0.00993	0.0101	CcSEcCtD
Levorphanol—Arrhythmia—Fluorouracil—colon cancer	0.00951	0.00965	CcSEcCtD
Levorphanol—Muscle spasms—Irinotecan—colon cancer	0.0093	0.00944	CcSEcCtD
Levorphanol—Agitation—Vincristine—colon cancer	0.00913	0.00926	CcSEcCtD
Levorphanol—Dysuria—Capecitabine—colon cancer	0.00869	0.00882	CcSEcCtD
Levorphanol—Convulsion—Vincristine—colon cancer	0.0086	0.00873	CcSEcCtD
Levorphanol—Lethargy—Methotrexate—colon cancer	0.00817	0.00829	CcSEcCtD
Levorphanol—Renal failure—Capecitabine—colon cancer	0.00814	0.00826	CcSEcCtD
Levorphanol—Convulsion—Fluorouracil—colon cancer	0.00803	0.00815	CcSEcCtD
Levorphanol—Confusional state—Irinotecan—colon cancer	0.00796	0.00808	CcSEcCtD
Levorphanol—Hyperhidrosis—Vincristine—colon cancer	0.00784	0.00795	CcSEcCtD
Levorphanol—Shock—Irinotecan—colon cancer	0.00777	0.00788	CcSEcCtD
Levorphanol—Hyperhidrosis—Irinotecan—colon cancer	0.00763	0.00774	CcSEcCtD
Levorphanol—Confusional state—Fluorouracil—colon cancer	0.00762	0.00774	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—colon cancer	0.00758	0.00769	CcSEcCtD
Levorphanol—Hypotension—Vincristine—colon cancer	0.00757	0.00769	CcSEcCtD
Levorphanol—Bradycardia—Capecitabine—colon cancer	0.00757	0.00768	CcSEcCtD
Levorphanol—Tachycardia—Fluorouracil—colon cancer	0.00738	0.00749	CcSEcCtD
Levorphanol—Hypotension—Irinotecan—colon cancer	0.00738	0.00749	CcSEcCtD
Levorphanol—Insomnia—Vincristine—colon cancer	0.00733	0.00744	CcSEcCtD
Levorphanol—Visual impairment—Capecitabine—colon cancer	0.00717	0.00727	CcSEcCtD
Levorphanol—Insomnia—Irinotecan—colon cancer	0.00714	0.00725	CcSEcCtD
Levorphanol—Hypotension—Fluorouracil—colon cancer	0.00706	0.00717	CcSEcCtD
Levorphanol—Dyspepsia—Irinotecan—colon cancer	0.00695	0.00705	CcSEcCtD
Levorphanol—Constipation—Vincristine—colon cancer	0.00693	0.00703	CcSEcCtD
Levorphanol—Flushing—Capecitabine—colon cancer	0.0069	0.007	CcSEcCtD
Levorphanol—Insomnia—Fluorouracil—colon cancer	0.00684	0.00694	CcSEcCtD
Levorphanol—Constipation—Irinotecan—colon cancer	0.00675	0.00685	CcSEcCtD
Levorphanol—Dyspepsia—Fluorouracil—colon cancer	0.00665	0.00675	CcSEcCtD
Levorphanol—Arrhythmia—Capecitabine—colon cancer	0.00664	0.00674	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vincristine—colon cancer	0.00663	0.00673	CcSEcCtD
Levorphanol—Feeling abnormal—Irinotecan—colon cancer	0.0065	0.0066	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—colon cancer	0.00647	0.00656	CcSEcCtD
Levorphanol—Gastrointestinal pain—Irinotecan—colon cancer	0.00645	0.00655	CcSEcCtD
Levorphanol—Abdominal pain—Vincristine—colon cancer	0.00641	0.0065	CcSEcCtD
Levorphanol—Abdominal pain—Irinotecan—colon cancer	0.00624	0.00633	CcSEcCtD
Levorphanol—Feeling abnormal—Fluorouracil—colon cancer	0.00623	0.00632	CcSEcCtD
Levorphanol—Muscle spasms—Capecitabine—colon cancer	0.00622	0.00632	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—colon cancer	0.00606	0.00615	CcSEcCtD
Levorphanol—Urticaria—Fluorouracil—colon cancer	0.00601	0.0061	CcSEcCtD
Levorphanol—Sweating—Methotrexate—colon cancer	0.00591	0.006	CcSEcCtD
Levorphanol—Palpitations—Capecitabine—colon cancer	0.00572	0.00581	CcSEcCtD
Levorphanol—Dry mouth—Capecitabine—colon cancer	0.00539	0.00547	CcSEcCtD
Levorphanol—Dizziness—Vincristine—colon cancer	0.00536	0.00544	CcSEcCtD
Levorphanol—Pruritus—Fluorouracil—colon cancer	0.00535	0.00543	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—colon cancer	0.00533	0.00541	CcSEcCtD
Levorphanol—Confusional state—Capecitabine—colon cancer	0.00533	0.00541	CcSEcCtD
Levorphanol—Dizziness—Irinotecan—colon cancer	0.00522	0.0053	CcSEcCtD
Levorphanol—Shock—Capecitabine—colon cancer	0.0052	0.00528	CcSEcCtD
Levorphanol—Tachycardia—Capecitabine—colon cancer	0.00516	0.00523	CcSEcCtD
Levorphanol—Vomiting—Vincristine—colon cancer	0.00515	0.00523	CcSEcCtD
Levorphanol—Rash—Vincristine—colon cancer	0.00511	0.00519	CcSEcCtD
Levorphanol—Hyperhidrosis—Capecitabine—colon cancer	0.00511	0.00518	CcSEcCtD
Levorphanol—Dermatitis—Vincristine—colon cancer	0.00511	0.00518	CcSEcCtD
Levorphanol—Vomiting—Irinotecan—colon cancer	0.00502	0.00509	CcSEcCtD
Levorphanol—Dizziness—Fluorouracil—colon cancer	0.005	0.00507	CcSEcCtD
Levorphanol—Rash—Irinotecan—colon cancer	0.00498	0.00505	CcSEcCtD
Levorphanol—Dermatitis—Irinotecan—colon cancer	0.00497	0.00505	CcSEcCtD
Levorphanol—Hypotension—Capecitabine—colon cancer	0.00494	0.00501	CcSEcCtD
Levorphanol—Nausea—Vincristine—colon cancer	0.00481	0.00489	CcSEcCtD
Levorphanol—Vomiting—Fluorouracil—colon cancer	0.00481	0.00488	CcSEcCtD
Levorphanol—Insomnia—Capecitabine—colon cancer	0.00478	0.00485	CcSEcCtD
Levorphanol—Rash—Fluorouracil—colon cancer	0.00477	0.00484	CcSEcCtD
Levorphanol—Dermatitis—Fluorouracil—colon cancer	0.00476	0.00483	CcSEcCtD
Levorphanol—Nausea—Irinotecan—colon cancer	0.00469	0.00476	CcSEcCtD
Levorphanol—Dyspepsia—Capecitabine—colon cancer	0.00465	0.00472	CcSEcCtD
Levorphanol—Constipation—Capecitabine—colon cancer	0.00452	0.00459	CcSEcCtD
Levorphanol—Morphine—ABCB1—colon cancer	0.0045	0.307	CrCbGaD
Levorphanol—Nausea—Fluorouracil—colon cancer	0.00449	0.00456	CcSEcCtD
Levorphanol—Feeling abnormal—Capecitabine—colon cancer	0.00435	0.00442	CcSEcCtD
Levorphanol—Gastrointestinal pain—Capecitabine—colon cancer	0.00432	0.00438	CcSEcCtD
Levorphanol—Urticaria—Capecitabine—colon cancer	0.0042	0.00426	CcSEcCtD
Levorphanol—Abdominal pain—Capecitabine—colon cancer	0.00418	0.00424	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—colon cancer	0.00418	0.00424	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—colon cancer	0.00397	0.00402	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—colon cancer	0.0038	0.00386	CcSEcCtD
Levorphanol—Dextromethorphan—ABCB1—colon cancer	0.00378	0.258	CrCbGaD
Levorphanol—Pruritus—Capecitabine—colon cancer	0.00374	0.00379	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—colon cancer	0.00368	0.00373	CcSEcCtD
Levorphanol—Estrone—ABCB1—colon cancer	0.00363	0.247	CrCbGaD
Levorphanol—Insomnia—Methotrexate—colon cancer	0.00356	0.00361	CcSEcCtD
Levorphanol—Dizziness—Capecitabine—colon cancer	0.00349	0.00355	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—colon cancer	0.00346	0.00351	CcSEcCtD
Levorphanol—Vomiting—Capecitabine—colon cancer	0.00336	0.00341	CcSEcCtD
Levorphanol—Rash—Capecitabine—colon cancer	0.00333	0.00338	CcSEcCtD
Levorphanol—Dermatitis—Capecitabine—colon cancer	0.00333	0.00338	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—colon cancer	0.00324	0.00329	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—colon cancer	0.00322	0.00326	CcSEcCtD
Levorphanol—Nausea—Capecitabine—colon cancer	0.00314	0.00318	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—colon cancer	0.00312	0.00317	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—colon cancer	0.00311	0.00316	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—colon cancer	0.00278	0.00282	CcSEcCtD
Levorphanol—Estradiol—ABCB1—colon cancer	0.00275	0.188	CrCbGaD
Levorphanol—Dizziness—Methotrexate—colon cancer	0.0026	0.00264	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—colon cancer	0.0025	0.00254	CcSEcCtD
Levorphanol—Rash—Methotrexate—colon cancer	0.00248	0.00252	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—colon cancer	0.00248	0.00251	CcSEcCtD
Levorphanol—Nausea—Methotrexate—colon cancer	0.00234	0.00237	CcSEcCtD
